Tumor vaccination that enhances antitumor T-cell responses does not inhibit the growth of established tumors even in combination with interleukin-12 treatment: The importance of inducing intratumoral T-cell migration

Journal of Immunotherapy

Volumn 23, Issue 6, 2000, Pages 643-653

  Gao, P ^a   Uekusa, Y ^a   Nakajima, C ^a   Iwasaki, M ^a   Nakahira, M ^a   Yang, Y F ^a   Ono, S ^a   Tsujimura, T ^a   Fujiwara, H ^a   Hamaoka, T ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Interleukin 12; T cell migration; Tumor vaccination

Indexed keywords

RECOMBINANT INTERLEUKIN 12; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNIZATION; CELLULAR IMMUNITY; CONTROLLED STUDY; LYMPHOCYTE MIGRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR MODEL; TUMOR REGRESSION;

ANIMALS; ANTIGENS, NEOPLASM; BIOLOGICAL RESPONSE MODIFIERS; CANCER VACCINES; CELL DIVISION; COMBINED MODALITY THERAPY; FIBROSARCOMA; HISTOCOMPATIBILITY ANTIGENS; INTERLEUKIN-12; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0033708117     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200011000-00005     Document Type: Article

References (33)

1. Immunogenic (tum-) variants of mouse tumor P815: Cloning of the gene of tum- antigen P91A and identification of the tum- mutation
2. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
3. Genes coding for tumor antigens recognized by cytolytic T lymphocytes
4. Regulatory mechanisms of antitumor T cell responses in the tumor-bearing state
5. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
6. Loss of T-cell receptor ζ chain and p56 lck in T-cells infiltrating human renal cell carcinoma
7. Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma
8. Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes
9. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: Role of soluble products from human renal cell carcinomas
10. T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-β
11. Immunosuppression and transforming growth factor-β in glioblastoma. Preferential production of transforming growth factor-β 2
12. Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-beating state
13. Inhibition of cytotoxic T cell development by transforming growth factor β and reversal by recombinant tumor necrosis factor α
14. Systemic administration of rIL-12 induces complete tumor regression and protective immunity: Response is correlated with a striking reversal of suppressed IFN-γ production by anti-tumor T cells
15. Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes
16. Molecular mechanisms underlying IFN-γ-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12
17. A critical role for a peritumoral stromal reaction in the induction of T-cell migration responsible for interleukin-12-induced tumor regression
18. Recognition of RSV-induced tumor cells in syngeneic mice and semisyngeneic reciprocal hybrid mice
19. High gradient magnetic cell separation with MACS
20. Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites after administration of interleukin 12
21. IL-12 receptor. II. Distribution and regulation of receptor expression
22. IL-12 produced by antigen-presenting cells induces IL-2-independent proliferation of T helper cell clones
23. Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-γ in response to IL-18
24. A sequence of cellular and molecular events involved in IL12-induced tumor regression
25. Cellular and molecular mechanisms underlying IL-12-induced tumor regression
26. Induction of interferon γ production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers
27. Multiple roles of interferon-γ in the mediation of interleukin 12-induced tumor regression
28. Tumor stroma
29. Stromal aspects of breast carcinoma
30. Angiogenesis
31. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
32. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration
33. Lymphocyte homing and homeostasis